Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies

被引:1
|
作者
Paranjpe, Madhav G. [1 ]
Belich, Jessica L. [1 ]
Richardson, Dayauna R. [1 ]
Vidmar, Tom [2 ]
Mann, Peter C. [3 ]
McKeon, Marie E. [1 ]
Elbekai, Reem H. [4 ]
Brown, Caren [1 ]
机构
[1] BioReliance SAFC, 14920 Broschart Rd, Rockville, MD 20850 USA
[2] BioSTAT Consultants Inc, Portage, MI USA
[3] Expt Pathol Labs, Seattle, WA USA
[4] PAREXEL Int, Bethesda, MD USA
关键词
Tg.rasH2; nasal cavity; exudative inflammation; historical incidence; nasal cavity tumors; carcinogenicity studies; RATS; REFLUX;
D O I
10.1177/1091581816673583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three levels of nasal cavity sections (anterior, middle, and most posterior) are routinely examined as protocol required tissues in our 26-week carcinogenicity studies involving Tg.rasH2 mice. Exudative inflammation of the nasal cavity was noted in the most posterior section of both males and females that were administered vehicle and/or test article via oral gavage, particularly when the vehicle and/or test article had irritant properties, was in the form of a salt, had a low pH, and/or was viscous. The exudative inflammatory lesion was characterized by the presence of eosinophilic proteinaceous fluid, fibrin, mucin, sloughed cells, and degenerate neutrophils within the nasal cavities. In lesions of increased severity, there was often degeneration, necrosis, and erosion of the underlying mucosa. Often, there was hyperplasia as well as squamous metaplasia of the mucosa. Retrospective analysis of our data, involving thirty-two 26-week Tg.rasH2 carcinogenicity studies, revealed that despite the presence of these exudative inflammatory changes with degeneration, necrosis, and mucosal hyperplasia, progression to tumor formation in the nasal cavities was rare and the incidence of nasal tumors was comparable in animals with or without exudative inflammatory lesions.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 44 条
  • [1] Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies
    Paranjpe, Madhav G.
    Belich, Jessica L.
    McKeon, Marie E.
    Elbekai, Reem H.
    Mann, Peter C.
    Hard, Gordon C.
    Seely, John C.
    [J]. TOXICOLOGIC PATHOLOGY, 2016, 44 (05) : 633 - 635
  • [2] Renal Tumors in 26-Week Tg.rasH2 Mouse Carcinogenicity Studies
    McKeon, M. E.
    Paranjpe, M. G.
    Elbekai, R. H.
    Belich, J. L.
    Mann, P. C.
    Hard, G. C.
    Seely, J. C.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2016, 35 (01) : 79 - 79
  • [3] Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies
    Paranjpe, Madhav G.
    Belich, Jessica L.
    Richardson, Dayauna R.
    Vidmar, Tom
    Mann, Peter C.
    McKeon, Marie E.
    Elbekai, Reem H.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (01) : 29 - 34
  • [4] Exudative inflammatory lesions in the nasal cavity in 28-day dose range finding studies in CByB6F1 mice and in 26-week carcinogenicity studies in Tg.rasH2 mice
    McKeon, Marie
    Elbekai, Reem H.
    Paranjpe, Mahdav
    Bruning, David
    [J]. TOXICOLOGY LETTERS, 2014, 229 : S151 - S151
  • [5] Evaluation of doses in the 26 week Tg.rasH2 mice carcinogenicity studies
    Elbekai, R.
    Paranjpe, M.
    [J]. TOXICOLOGY LETTERS, 2015, 238 (02) : S239 - S240
  • [6] A Proposal for New Strategies in Dose Selection for 26-Week Tg.Rash2 Carcinogenicity Studies
    Paranjpe, Madhav G.
    Vidmar, Tom J.
    Denton, Melissa D.
    Elbekai, Reem H.
    Mann, Peter C.
    Mckeon, Marie
    Brown, Caren
    Martineck, John
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (04) : 311 - 321
  • [7] Approaches for Reducing the Number of Animals Used for 26-Week Alternate Carcinogenicity Studies in Transgenic Mice (Tg.rasH2)
    Shah, Sudhir A.
    Paranjpe, Madhav G.
    Wenk, Martin. L.
    Zahalka, Eias A.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2011, 30 (01) : 110 - 110
  • [8] Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies
    Paranjpe, Madhav G.
    Belich, Jessica
    Vidmar, Tom J.
    Elbekai, Reem H.
    McKeon, Marie
    Brown, Caren
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (04) : 287 - 292
  • [9] High Background Incidence of Spontaneous Subcapsular Adrenal Gland Hyperplasia of Tg.rasH2 Mice Used in 26-week Carcinogenicity Studies
    Boyle, Molly H.
    Paranjpe, Madhav G.
    Creasy, Dianne M.
    [J]. TOXICOLOGIC PATHOLOGY, 2018, 46 (04) : 444 - 448
  • [10] Proposal to Eliminate Urethane-Treated Positive Control Dose Groups in 26-Week Tg.rasH2 Carcinogenicity Studies
    Paranjpe, Madhav G.
    Rudmann, Daniel
    Sargeant, Aaron
    Morse, Mark
    Yonpiam, Rossalin
    Bonnette, Kimberly
    Albretsen, Jay
    Papagiannis, Christopher
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (03) : 207 - 210